July 23, 2014 6:46 PM ET


Company Overview of Human Genome Sciences Inc.

Company Overview

Human Genome Sciences, Inc. operates as a biopharmaceutical company in the United States. Its principal products include BENLYSTA for systemic lupus erythematosus; and raxibacumab for inhalation anthrax. The company’s mid- and early-stage pipeline products comprise Mapatumumab, a human monoclonal antibody for the treatment of advanced hepatocellular cancer; HGS1036, a biologic for multiple cancers; HGS1029, an IAP inhibitor that is in Phase 1 development to treat patients with solid and lymphoid tumors; and HGS1025, a human monoclonal antibody to the CCR5 receptor that would have entered Phase 1b development in ulcerative colitis. It also holds financial rights to certain products in the Gla...

14200 Shady Grove Road

Rockville, MD 20850-7464

United States

Founded in 1992

1,100 Employees





Key Executives for Human Genome Sciences Inc.

Chief Executive
Age: 53
Chief Financial Officer and Director
Senior Vice President of Operations
Age: 52
Executive Vice President
Age: 62
Executive Vice President of Research & Development
Age: 64
Compensation as of Fiscal Year 2014.

Human Genome Sciences Inc. Key Developments

GSK Reportedly To Acquire Human Genome

GlaxoSmithKline plc (LSE:GSK) is reportedly expected to announce an agreement to acquire Human Genome Sciences Inc. for about $2.8 billion. GlaxoSmithKline is expected to pay around $14 per share.

Human Genome Sciences Plans 97 More Layoffs in Rockville

Human Genome Sciences Inc. plans to cut an additional 97 positions in Rockville later this year and more layoffs could be on the way. The jobs to be eliminated are part of an ongoing internal restructuring plan, according to the notice with the Maryland Department of Labor, Licensing and Regulation. The layoffs will begin on December 15. Human Genome also told the state a third phase of terminations are projected to begin around November 30 with subsequent phases of job cuts occurring in 2013.

Human Genome Sciences Inc. Presents at BIO Convention in China, Oct-24-2012

Human Genome Sciences Inc. Presents at BIO Convention in China, Oct-24-2012 . Venue: Kerry Hotel, No.1388 Hua Mu Road, Pudong, Shanghai 201204, China.

Similar Private Companies By Industry

Company Name Region
Coherus Biosciences Inc United States
AxCell Biosciences Corporation United States
On Target Laboratories, LLC United States
TGG Medical Transitory, Inc. United States
Avra Medicines, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Human Genome Sciences Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.